NASDAQ Composite ended the session with Bionano Genomics rising 9.76% to $5.91 on Wednesday while nASDAQ Composite rose 1.19% to $13,950.22.
Bionano Genomics today’s close was $5.91, 165.48% under its 52-week high of $15.69.
Bionano Genomics’s Sales
Bionano Genomics’s sales growth is 154.4% for the ongoing quarter and 203.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 86.7% and 44.4%, respectively.
Bionano Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 43%, now sitting on 8.5M for the twelve trailing months.
Bionano Genomics’s last day, last week, and last month’s current volatility was 2.09%, 5.97%, and 5.11%, respectively.
Bionano Genomics‘s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 18.32% (day), 11.10% (last week), and 9.12% (last month), respectively.
Bionano Genomics’s Stock Yearly Top and Bottom Value
Bionano Genomics’s stock is valued at $5.91 at 17:23 EST, way under its 52-week high of $15.69 and way higher than its 52-week low of $0.28.
Bionano Genomics’s Moving Average
Bionano Genomics’s value is way under its 50-day moving average of $9.47 and way higher than its 200-day moving average of $4.64.
More news about Bionano Genomics.